NeuroPace (NPCE) Net Margin (2020 - 2026)

NeuroPace's Net Margin history runs 7 years deep, the most recent figure standing at 99.54% for Q1 2026.

• On a quarterly basis, Net Margin fell 7044.0% year-over-year to 99.54% in Q1 2026; TTM through Mar 2026 was 53.01%, a 2326.0% decrease from a year earlier, with the FY2025 full-year figure at 36.04%, up 8515.0% from the prior year.
• Net Margin fell to 99.54% in Q1 2026 per NPCE's latest filing, from 14.48% in the prior quarter.
• Across five years, Net Margin topped out at 14.48% in Q4 2025 and bottomed at 123.58% in Q2 2022.
• The 5-year median for Net Margin is 49.76% (2024), against an average of 59.59%.
• Across the five-year window, Net Margin tumbled 7308 bps in 2022 and soared 6758 bps in 2023, its largest moves.
• Year by year, Net Margin stood at 86.01% in 2022, then soared by 59 bps to 35.69% in 2023, then surged by 32 bps to 24.09% in 2024, then soared by 40 bps to 14.48% in 2025, then plunged by 587 bps to 99.54% in 2026.
• Per Business Quant, the three latest NPCE Net Margin figures stand at 99.54% (Q1 2026), 14.48% (Q4 2025), and 18.22% (Q3 2025).